BioClinica and Medidata advance with EDC offerings; Genizon falls behind new genomics tech, shuts doors;

> BioClinica ($BIOC) has made the latest relase of its Express EDC software, with changes to improve the web-based software's ease of use. Release

> Montreal-based genomics firm Genizon Biosciences has shuttered its operations after, as one former exec tells Bio-IT World, the company fell behind new technology in the genomics field. News

> Japan's Chiba University Hospital Clinical Research Center, one of the country's largest research hubs, has signed on to begin using Medidata's ($MDSO) Rave software for its investigators' clinical trials. Release

> Dutch firm Skyline Diagnostics, which uses a bioinformatics engine in biomarker studies, has inked a deal with Clavis Pharma to find genetic markers for use in screening patients with acute myeloid leukemia who might benefit from Clavis's expiramental AML drug. Item

> JMP, a unit of Cary, NC-based analytics powerhouse SAS, said that it has made new releases of its JMP Genomics and JMP Clinical software, both of which "dynamically link SAS Analytics and JMP graphics to provide a comprehensive picture of research results." Announcement

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.